N-Acyl derivatives of glucosamines having antitumor chemotherape

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2601125R, 424180, 536 53, A61K 3700, C07C10352, A61K 3170

Patent

active

042162084

ABSTRACT:
N-Acyl derivatives of glucosamines made by linking an amino acid or oligopeptide having a m-di(2-chloroethyl)amino-L-phenylalanyl group, to the amino group of the glucosamines by a peptide bond, are endowed with strong anti-tumor action against transplanted neoplasma in animal. The compounds according to the present invention are of the general formula (I): ##STR1## where R.sub.1 is a hydrogen atom or an acetyl group,

REFERENCES:
Siggins et al., J.A.C.S. 1966, pp. 971-973.
Adam et al., Biochem. and Biophys. Res. Commun. 72, 1976, pp. 339-346.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

N-Acyl derivatives of glucosamines having antitumor chemotherape does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-Acyl derivatives of glucosamines having antitumor chemotherape, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-Acyl derivatives of glucosamines having antitumor chemotherape will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2280323

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.